PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 131 filers reported holding PROGENICS PHARMACEUTICALS IN in Q4 2019. The put-call ratio across all filers is 1.40 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $129,000 | -25.4% | 33,943 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $173,000 | +0.6% | 33,943 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $172,000 | -16.5% | 33,943 | +1.8% | 0.00% | -33.3% |
| Q2 2019 | $206,000 | +35.5% | 33,343 | +1.8% | 0.00% | +50.0% |
| Q1 2019 | $152,000 | +12.6% | 32,743 | +1.8% | 0.00% | 0.0% |
| Q4 2018 | $135,000 | – | 32,152 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|